4-氨基-3'-氯二苯乙烯 | 93535-04-7

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 二苯乙烯类
• 中文名称: 4-氨基-3'-氯二苯乙烯
• 英文名称: trans-4-Amino-3'-chlor-stilben
• 英文别名: (E)-4-(3-chlorostyryl)aniline；3'-chloro-trans-stilbenyl-(4)-amine；3'-Chlor-trans-stilbenyl-(4)-amin；4-Amino-3'-chlorostilbene；4-[(E)-2-(3-chlorophenyl)ethenyl]aniline
• CAS: 93535-04-7
• 化学式: C₁₄H₁₂ClN
• 分子量: 229.709
• InChiKey: IPJQKOADVGRNMS-SNAWJCMRSA-N

物化性质

• 沸点：
  397.9±31.0 °C(Predicted)
• 密度：
  1.229±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  4-氨基-3'-氯二苯乙烯 在 sodium hydride 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 4.5h， 生成 (E)-1-(4-(3-chlorostyryl)phenyl)imidazolidin-2-one
  参考文献：
  名称：

  Styryl-N-phenyl-N′-(2-chloroethyl)ureas and styrylphenylimidazolidin-2-ones as new potent microtubule-disrupting agents using combretastatin A-4 as model

  摘要：

  Combretastatin A-4 (CA-4) is a well-studied and attractive molecular template to develop new antimitotics. Several thousand of modifications were performed on the ring B and the ethenyl bridge of CA-4 but only a few involved the trimethoxyphenyl moiety (TMP, ring A) often considered essential to the antiproliferative and antimicrotubule activities. In this study, we described the design, the preparation, the characterization and the biological evaluation of three new series of CA-4 analogs namely styryl-N-phenyl-N'-ethylureas (SEUs), styryl-N-phenyl-N'-(2-chloroethyl)ureas (SCEUs) and styrylphenylimidazolidin-2-ones (SIMZs) bearing a 3-Cl (series a), 3,5-Me (series b) and TMP (series c) substituents, respectively. All SCEU and SIMZ Z-isomers were active in the high and the low nanomolar range, respectively. Conversely to SEUs and their E-isomers that were significantly less active or inactive. Interestingly, the IMP moiety is giving rise to derivatives exhibiting the lowest antiproliferative activity in the SCEU series (10c) and the most active compound in the SIMZ series (12c). Moreover, SIMZ Z-isomers bearing either a 3-Cl (12a) or a 3,5-Me (12b) exhibited antiproliferative activities that are also in the same order of magnitude as 12c. All SCEU and SIMZ Z-isomers also arrested the cell cycle progression in G2/M phase, bound to the colchicine-binding site and disrupted the cytoskeleton of cancer cells. In addition to the promising and innovative microtubule-disrupting properties of SCEUs and SIMZs, these results show that the IMP moiety is not essential for the cytocidal activity of these new CA-4 analogs. (C) 2015 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2015.05.034
• 作为产物：
  描述：

  4-硝基苄基三苯基溴蓊盐 在 盐酸 、 铁粉 、 sodium hydride 作用下， 以 乙醇 、 二氯甲烷 、 水 为溶剂， 反应 28.0h， 生成 4-氨基-3'-氯二苯乙烯
  参考文献：
  名称：

  Styryl-N-phenyl-N′-(2-chloroethyl)ureas and styrylphenylimidazolidin-2-ones as new potent microtubule-disrupting agents using combretastatin A-4 as model

  摘要：

  Combretastatin A-4 (CA-4) is a well-studied and attractive molecular template to develop new antimitotics. Several thousand of modifications were performed on the ring B and the ethenyl bridge of CA-4 but only a few involved the trimethoxyphenyl moiety (TMP, ring A) often considered essential to the antiproliferative and antimicrotubule activities. In this study, we described the design, the preparation, the characterization and the biological evaluation of three new series of CA-4 analogs namely styryl-N-phenyl-N'-ethylureas (SEUs), styryl-N-phenyl-N'-(2-chloroethyl)ureas (SCEUs) and styrylphenylimidazolidin-2-ones (SIMZs) bearing a 3-Cl (series a), 3,5-Me (series b) and TMP (series c) substituents, respectively. All SCEU and SIMZ Z-isomers were active in the high and the low nanomolar range, respectively. Conversely to SEUs and their E-isomers that were significantly less active or inactive. Interestingly, the IMP moiety is giving rise to derivatives exhibiting the lowest antiproliferative activity in the SCEU series (10c) and the most active compound in the SIMZ series (12c). Moreover, SIMZ Z-isomers bearing either a 3-Cl (12a) or a 3,5-Me (12b) exhibited antiproliferative activities that are also in the same order of magnitude as 12c. All SCEU and SIMZ Z-isomers also arrested the cell cycle progression in G2/M phase, bound to the colchicine-binding site and disrupted the cytoskeleton of cancer cells. In addition to the promising and innovative microtubule-disrupting properties of SCEUs and SIMZs, these results show that the IMP moiety is not essential for the cytocidal activity of these new CA-4 analogs. (C) 2015 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2015.05.034

文献信息

• Mizoroki-Heck Reactions Catalyzed by Dichloro{bis[1-(dicyclohexylphosphanyl)piperidine]}palladium: Palladium Nanoparticle Formation Promoted by (Water-Induced) Ligand Degradation
  作者：Miriam Oberholzer、Roman Gerber、Christian M. Frech

  DOI：10.1002/adsc.201100646

  日期：2012.3

  excellent functional group tolerance, which reliably operates at low catalyst loadings. Various activated, non‐activated, deactivated, functionalized, sterically hindered, and heterocyclic aryl bromides, which may contain nitro, chloro or trifluoromethane groups, nitriles, acetales, ketones, aldehydes, ethers, esters, lactones, amides, anilines, phenols, alcohols, carboxylic acids, and heterocyclic aryl

  钯基二氯双[1-（二环己基膦酰基）哌啶]络合物– [（P （NC 5 H 10）（C 6 H 11）2 }）2 Pd（Cl）2 ]易于从反应中定量获得N 2下的[Pd（cod）（Cl）2 ]（cod = cycloocta-1,5-diene）与甲苯中两当量的1-（dicyclohexylphosphanyl）piperidine的合成在室温下仅需几分钟。该配合物是具有出色的官能团耐受性的高活性Heck催化剂，可在低催化剂负载下可靠地运行。各种活化的，未活化的，失活的，官能化的，位阻的和杂环的芳基溴化物，它们可能包含硝基，氯或三氟甲烷基团，腈，乙缩醛，酮，醛，醚，酯，内酯，酰胺，苯胺，苯酚，酚，醇，羧酸和杂环芳基溴化物（例如吡啶和衍生物）以及含有甲基硫烷基的噻吩和芳基溴化物已成功地与各种（也官能化的）烯烃偶联，并具有优异的收率和选择性（E-异构体通常是在140°C下在DMF中0.05 m
• Veschambre,H.; Kergomard,A., Bulletin de la Societe Chimique de France, 1966, p. 336 - 342
  作者：Veschambre,H.、Kergomard,A.

  DOI：——

  日期：——
• Haddow et al., Philosophical transactions of the Royal Society of London. Series A, Mathematical and physical sciences, 1948, vol. 241, p. 147,186
  作者：Haddow et al.

  DOI：——

  日期：——
• Inhibition of monoamine oxidase by (E)-styrylisatin analogues
  作者：Elizna M. Van der Walt、Erika M. Milczek、Sarel F. Malan、Dale E. Edmondson、Neal Castagnoli、Jacobus J. Bergh、Jacobus P. Petzer

  DOI：10.1016/j.bmcl.2009.03.030

  日期：2009.5

  Previous studies have shown that (E)-8-(3-chlorostyryl) caffeine (CSC) is a specific reversible inhibitor of human monoamine oxidase B (MAO-B) and does not bind to human MAO-A. Since the small molecule isatin is a natural reversible inhibitor of both MAO-B and MAO-A, (E)-5-styrylisatin and (E)-6-styrylisatin analogues were synthesized in an attempt to identify inhibitors with enhanced potencies and specificities for MAO-B. The (E)-styrylisatin analogues were found to exhibit higher binding affinities than isatin with the MAO preparations tested. The (E)-5-styrylisatin analogues bound more tightly than the (E)-6 analogue although the latter exhibits the highest MAO-B selectivity. Molecular docking studies with MAO-B indicate that the increased binding affinity exhibited by the (E)-styrylisatin analogues, in comparison to isatin, is best explained by the ability of the styrylisatins to bridge both the entrance cavity and the substrate cavity of the enzyme. Experimental support for this model is shown by the weaker binding of the analogues to the Ile199Ala mutant of human MAO-B. The lower selectivity of the (E)-styrylisatin analogues between MAO-A and MAO-B, in contrast to CSC, is best explained by the differing relative geometries of the aromatic rings for these two classes of inhibitors. (C) 2009 Elsevier Ltd. All rights reserved.
• Styryl-N-phenyl-N′-(2-chloroethyl)ureas and styrylphenylimidazolidin-2-ones as new potent microtubule-disrupting agents using combretastatin A-4 as model
  作者：Mathieu Gagné-Boulet、Sébastien Fortin、Jacques Lacroix、Carole-Anne Lefebvre、Marie-France Côté、René C.-Gaudreault

  DOI：10.1016/j.ejmech.2015.05.034

  日期：2015.7

  Combretastatin A-4 (CA-4) is a well-studied and attractive molecular template to develop new antimitotics. Several thousand of modifications were performed on the ring B and the ethenyl bridge of CA-4 but only a few involved the trimethoxyphenyl moiety (TMP, ring A) often considered essential to the antiproliferative and antimicrotubule activities. In this study, we described the design, the preparation, the characterization and the biological evaluation of three new series of CA-4 analogs namely styryl-N-phenyl-N'-ethylureas (SEUs), styryl-N-phenyl-N'-(2-chloroethyl)ureas (SCEUs) and styrylphenylimidazolidin-2-ones (SIMZs) bearing a 3-Cl (series a), 3,5-Me (series b) and TMP (series c) substituents, respectively. All SCEU and SIMZ Z-isomers were active in the high and the low nanomolar range, respectively. Conversely to SEUs and their E-isomers that were significantly less active or inactive. Interestingly, the IMP moiety is giving rise to derivatives exhibiting the lowest antiproliferative activity in the SCEU series (10c) and the most active compound in the SIMZ series (12c). Moreover, SIMZ Z-isomers bearing either a 3-Cl (12a) or a 3,5-Me (12b) exhibited antiproliferative activities that are also in the same order of magnitude as 12c. All SCEU and SIMZ Z-isomers also arrested the cell cycle progression in G2/M phase, bound to the colchicine-binding site and disrupted the cytoskeleton of cancer cells. In addition to the promising and innovative microtubule-disrupting properties of SCEUs and SIMZs, these results show that the IMP moiety is not essential for the cytocidal activity of these new CA-4 analogs. (C) 2015 Elsevier Masson SAS. All rights reserved.